Healthcare M&A Watch 2014 Q3 Report Highlights
After a spate of pharmaceutical mega-mergers in Q2, total deal value plummeted 74% in Q3 2014
- The total reported purchase value sank to $60.7 billion, almost four times less than Q2's robust $233.2 billion.
- Three of the top five deals in Q3 2014 involved Pharma and biotech firms. The biggest: Merck's $17 billion offer for Sigma-Aldrich.
- The top five deals in Q3 2014 totaled $39.9 billion, a 77.3% drop from Q2 2014's $175.2 billion.
- Deal volume slipped slightly, with 285 deals in Q3 2014 compared to the 287 deals in Q2 2014, the high for the year so far.
Q: What is Healthcare M&A Watch?
A: Healthcare M&A Watch is a digital report produced on a quarterly basis that covers trending and analysis of U.S. mergers and acquisitions among providers, payers, vendors and pharma/life sciences sectors of the healthcare industry. You can purchase the quarterly report individually for $199.
Q: I have a paid ModernHealthcare.com subscription. Can I get the Healthcare M&A Watch for free?
A: Yes, if you are a Premium Web subscriber. Premium Web subscribers have access to all the By The Numbers PDFs and research from Modern Healthcare Insights that are uploaded to our Healthcare Business Data Center.